Patrick Quinlan, the CEO of Confience, a newly launched laboratory information management systems (LIMS) provider, spoke about the company’s strategic direction along with two executive hires during a meeting with reporters at Pittcon in San Diego, California. Confience, which was launched in January, was formed after the merger of Accelerated Technology Laboratories (ATL) and Quality Systems International (QSI). The company is backed by STG Partners, a private equity firm with more than $10 billion in assets under management.
“The year ahead is about expanding market presence, hitting ambitious product milestones, building a world-class team, and delivering a modern, customer-centric experience,” Quinlan said, in a press release about the announcement.
Quinlan also announced two new hires: Emad Georgy, the company’s new chief technology officer, and Jonathan Kalstein, the company’s chief financial officer. Georgy has held leadership positions at several large technology companies, including Experian and Wolters Kluwer. Kalstein previously served as chief financial officer at Zenput, Convercent, and Axcient. Confience currently has 40 employees working out of its headquarters in Frankfurt, Germany, and 60 employees in the United States.
“Effective, modern software has the potential to not only drive better business results, but also directly benefit consumer safety and quality outcomes to build brand trust, reduce corporate risk, and contribute to a safer world,” Georgy said in a press release.
Confience serves customers across food and beverage, manufacturing, product testing, air quality, and manufacturing industries. The company works with car manufacturers Mercedes and BMW in the European market, Quinlan said.
The company offers several products including the Titan LIMS, the Confience platform, Sample Maters LIMS, and WinLMS. Its WinLMS technology is used by companies including General Motors, Pepsico, and more.
Moving forward, Confience will continue to provide data-driven insights and reporting via a cloud-based, product-agnostic data platform, Quinlan said. The company plans to launch its global brand strategy in the European market in the spring of 2024.
USP CEO Discusses Quality and Partnership in Pharma
December 11th 2024Ronald Piervincenzi, chief executive officer of the United States Pharmacoepia, focused on how collaboration and component quality can improve worldwide pharmaceutical production standards during a lecture at the Eastern Analytical Symposium (EAS) last month.